understanding glp 1 GLP-1 for Weight Loss and Diabetes Understanding semaglutide (GLP-1 RA): Are

Trends Endocrinol Metab (2009) 20(10):47782

In a phase 2 clinical trial targeting obese individuals without type 2 diabetes (T2D), retatrutide dosed at 1 to 12 mg resulted in up to 24.2% weight loss over a 48-week treatment period, compared to 2.1% in the placebo group, and demonstrated a dose-dependent effect

Talking to Your Provider If youre currently breastfeeding and eager to start GLP-1 treatment, the most important step is having an honest conversation with your prescriber about your timeline

S.AshrafA.et al (2024)

Even at lower doses, GLP-1s carry risks of gastrointestinal issues, including nausea, constipation, and general abdominal discomfort